Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2016

01-06-2016 | Case Report

Concomitant Presence of Two Distinct Clones of Chronic Lymphocytic Leukemia and Plasma Cell Myeloma in a Patient

Authors: Sabina Langer, Meenal Mehta, Amrita Saraf, Aastha Gupta, Keyur Pipliya, Atul Kakar, Manorama Bhargava

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2016

Login to get access

Abstract

A 74 years old male patient, presented with history of generalized weakness, fatigue, loss of appetite and breathlessness on exertion for past one and a half months. On examination, he was found to have significant pallor and generalized lymphadenopathy (cervical, axillary and inguinal). The skeletal survey showed punched out lytic lesions in skull and pelvic bones. The peripheral smear examination showed lymphocytosis with absolute lymphocyte count of 25,000/μL. The bone marrow aspirates revealed a hypercellular marrow with 74 % lymphocytes & 14 % plasma cells, suggestive of chronic lymphoplasmacytic disorder. The bone marrow biopsy had two morphologically distinct populations of lymphocytes & plasma cells. The immunohistochemical markers on bone marrow biopsy showed hat plasma cells were positive for CD138 with kappa light chain restriction. Flow cytometry showed B cell population with CD19/CD5 co expression, CD5/CD23 coexpression, were positive for CD22, CD20 and negative for FMC-7 and lambda light chain. In addition, plasma cells were also identified as CD45 negative cells and showed CD38/CD138 co-expression with variable CD19 and CD56 positivity. Serum protein electrophoresis revealed M band, serum immunofixation electrophoresis corresponded to IgA -Kappa. The final diagnosis of chronic lymphocytic leukemia with concomittant presence of plasma cell myeloma was concluded. This case imparts an important message to look for presence of coexisting entities in a single specimen and highlights the benefits of testing both plasma cell and B-cell compartments when the clinical features are not entirely consistent Flow cytometry together with protein electrophoresis can help to clinch difficult and rare dual diagnosis. These cases are rare and pose therapeutic challenge.
Literature
1.
go back to reference Alley CL, Wang E, Dunphy CH, Gong JZ, Lu CM, Boswell EL, Burchette J, Lagoo AS (2013) Literature. Arch Pathol Lab Med 137(4):503–517CrossRefPubMed Alley CL, Wang E, Dunphy CH, Gong JZ, Lu CM, Boswell EL, Burchette J, Lagoo AS (2013) Literature. Arch Pathol Lab Med 137(4):503–517CrossRefPubMed
2.
go back to reference Carulli G, Ciancia EM, Azzarà A, Ottaviano V, Grassi S, Ciabatti E, Ferreri MI, Rocco M, Marini A, Petrini M (2013) Simultaneous presentation of Waldenström macroglobulinemia and multiple myeloma: multidisciplinary diagnosis, treatment and 30-month follow-up. J Clin Exp Hematop 53(1):29–36CrossRefPubMed Carulli G, Ciancia EM, Azzarà A, Ottaviano V, Grassi S, Ciabatti E, Ferreri MI, Rocco M, Marini A, Petrini M (2013) Simultaneous presentation of Waldenström macroglobulinemia and multiple myeloma: multidisciplinary diagnosis, treatment and 30-month follow-up. J Clin Exp Hematop 53(1):29–36CrossRefPubMed
3.
go back to reference Kaufmann H, Ackermann J, Nösslinger T, Krömer E, Zojer N, Schreiber S, Urbauer E, Heinz R, Ludwig H, Huber H, Drach J (2001) Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma–a report on two cases. Ann Hematol 80(8):474–478CrossRefPubMed Kaufmann H, Ackermann J, Nösslinger T, Krömer E, Zojer N, Schreiber S, Urbauer E, Heinz R, Ludwig H, Huber H, Drach J (2001) Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma–a report on two cases. Ann Hematol 80(8):474–478CrossRefPubMed
4.
go back to reference Molina TJ Lin P, Swerdlow SH Cook JR (2011) Marginal zone lymphomas with plasmacytic differentiation and related disorders. Am J Clin Pathol 136(2):211–225CrossRef Molina TJ Lin P, Swerdlow SH Cook JR (2011) Marginal zone lymphomas with plasmacytic differentiation and related disorders. Am J Clin Pathol 136(2):211–225CrossRef
5.
go back to reference Srinivasan S, Schiffer CA (2009) Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide. Leuk Res 33(4):561–564CrossRefPubMed Srinivasan S, Schiffer CA (2009) Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide. Leuk Res 33(4):561–564CrossRefPubMed
6.
go back to reference Chang H, Wechalekar A, Li L, Reece D (2004) Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization evidence of distinct clonal origin. Cancer Genet Cytogenet 148(1):44–48CrossRefPubMed Chang H, Wechalekar A, Li L, Reece D (2004) Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization evidence of distinct clonal origin. Cancer Genet Cytogenet 148(1):44–48CrossRefPubMed
7.
go back to reference Patriarca F, Gaidano G, Capello D, Zaja F, Fanin R, Baccarani M (2000) Occurrence of multiple myeloma after fludarabine treatment of a chronic Lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation. Haematologica 85(9):982–985PubMed Patriarca F, Gaidano G, Capello D, Zaja F, Fanin R, Baccarani M (2000) Occurrence of multiple myeloma after fludarabine treatment of a chronic Lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation. Haematologica 85(9):982–985PubMed
8.
go back to reference Saltman DL, Ross JA, Banks RE, Ross FM, Ford AM, Mackie MJ (1989) Molecular evidence for a single clonal origin in biphenotypic concomitant chronic lymphocytic leukemia and multiple myeloma. Blood 74(6):2062–2065PubMed Saltman DL, Ross JA, Banks RE, Ross FM, Ford AM, Mackie MJ (1989) Molecular evidence for a single clonal origin in biphenotypic concomitant chronic lymphocytic leukemia and multiple myeloma. Blood 74(6):2062–2065PubMed
9.
go back to reference Novak PM, Mattson JC, Crisan D, Chen J, Poulik MD, Decker D (1995) Separate clones in concomitant multiple myeloma and a second B-cell neoplasm demonstrated by molecular and immunophenotypic analysis. Eur J Haematol 54(4):254–261CrossRefPubMed Novak PM, Mattson JC, Crisan D, Chen J, Poulik MD, Decker D (1995) Separate clones in concomitant multiple myeloma and a second B-cell neoplasm demonstrated by molecular and immunophenotypic analysis. Eur J Haematol 54(4):254–261CrossRefPubMed
10.
go back to reference Devi VL, Prabhash K, Malathi M, Madhumathi DS, Bapsy PP (2004) Uncommon manifestations of common malignancies: case 2. Chronic lymphocytic leukemia and multiple myeloma in the same patient. J Clin Oncol 22(15):3192–3193CrossRefPubMed Devi VL, Prabhash K, Malathi M, Madhumathi DS, Bapsy PP (2004) Uncommon manifestations of common malignancies: case 2. Chronic lymphocytic leukemia and multiple myeloma in the same patient. J Clin Oncol 22(15):3192–3193CrossRefPubMed
11.
go back to reference Rogulj IM, Radić-Kristo D, Milunović V, Kolonić SO, Jelić-Puskarić B, Planinc-Peraica A (2011) Multiple myeloma in a patient with chronic lymphocytic leukemia—case report and literature review. Acta Med Croatica 65(Suppl 1):173–177PubMed Rogulj IM, Radić-Kristo D, Milunović V, Kolonić SO, Jelić-Puskarić B, Planinc-Peraica A (2011) Multiple myeloma in a patient with chronic lymphocytic leukemia—case report and literature review. Acta Med Croatica 65(Suppl 1):173–177PubMed
12.
go back to reference Aktan M, Akkaya A, Dogan O, Dincol G (2003) Chronic lymphocytic leukemiaAnd multiple myeloma in the same patient: case report. Leuk Lymphoma 44(8):1421–1424CrossRefPubMed Aktan M, Akkaya A, Dogan O, Dincol G (2003) Chronic lymphocytic leukemiaAnd multiple myeloma in the same patient: case report. Leuk Lymphoma 44(8):1421–1424CrossRefPubMed
13.
go back to reference Bassan R, Comotti B, Minetti B, Viero P, Barbui T (1984) Concurrent multiple myeloma and chronic lymphocytic leukemia. Am J Clin Pathol 82(5):624–627CrossRefPubMed Bassan R, Comotti B, Minetti B, Viero P, Barbui T (1984) Concurrent multiple myeloma and chronic lymphocytic leukemia. Am J Clin Pathol 82(5):624–627CrossRefPubMed
14.
go back to reference Shpilberg O, Mark Z, Biniaminov M et al (1995) Transformation of chronic lymphocytic leukemia to multiple myeloma: clonal evolution of second malignancy? Leukemia 9(11):1974–1978PubMed Shpilberg O, Mark Z, Biniaminov M et al (1995) Transformation of chronic lymphocytic leukemia to multiple myeloma: clonal evolution of second malignancy? Leukemia 9(11):1974–1978PubMed
15.
go back to reference Fermand JP, James JM, Herait P, Brouet JC (1985) Associated chronic lymphocytic leukemia and multiple myeloma: origin from a single clone. Blood 66(2):291–293PubMed Fermand JP, James JM, Herait P, Brouet JC (1985) Associated chronic lymphocytic leukemia and multiple myeloma: origin from a single clone. Blood 66(2):291–293PubMed
16.
go back to reference Pines A, Ben-Bassat I, Selzer G, Ramot B (1984) Transformation of chronic Lymphocytic leukemia to plasmacytoma. Cancer 54(9):1904–1907CrossRefPubMed Pines A, Ben-Bassat I, Selzer G, Ramot B (1984) Transformation of chronic Lymphocytic leukemia to plasmacytoma. Cancer 54(9):1904–1907CrossRefPubMed
17.
go back to reference Kontozoglou T, Skinnider LF (1983) Concurrent appearance of multiple myeloma with other B-cell lymphoid neoplasms: a report of two cases. Arch Pathol Lab Med 107(5):232–234PubMed Kontozoglou T, Skinnider LF (1983) Concurrent appearance of multiple myeloma with other B-cell lymphoid neoplasms: a report of two cases. Arch Pathol Lab Med 107(5):232–234PubMed
18.
go back to reference Brouet JC, Fermand JP, Laurent G et al (1985) The association of chronic lymphocytic leukaemia and multiple myeloma: a study of eleven patients. Br J Haematol 59(1):55–66CrossRefPubMed Brouet JC, Fermand JP, Laurent G et al (1985) The association of chronic lymphocytic leukaemia and multiple myeloma: a study of eleven patients. Br J Haematol 59(1):55–66CrossRefPubMed
19.
go back to reference Pantic M, Schroettner P, Pfeifer D et al (2010) Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma. Leukemia 24(4):885–890CrossRefPubMed Pantic M, Schroettner P, Pfeifer D et al (2010) Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma. Leukemia 24(4):885–890CrossRefPubMed
20.
go back to reference Hasskarl J, Ihorst G, De Pasquale D et al (2011) Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma. Leuk Lymphoma 52(2):247–259CrossRefPubMed Hasskarl J, Ihorst G, De Pasquale D et al (2011) Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma. Leuk Lymphoma 52(2):247–259CrossRefPubMed
21.
go back to reference Howard MT, Hodnefield J, Morice WG (2011) Immunohistochemical phenotyping of plasma cells in lymphoplasmacytic lymphoma/Waldenström’s macroglobulinemia is comparable to flow cytometric techniques. Clin Lymphoma Myeloma Leuk 11(1):96–98CrossRefPubMed Howard MT, Hodnefield J, Morice WG (2011) Immunohistochemical phenotyping of plasma cells in lymphoplasmacytic lymphoma/Waldenström’s macroglobulinemia is comparable to flow cytometric techniques. Clin Lymphoma Myeloma Leuk 11(1):96–98CrossRefPubMed
Metadata
Title
Concomitant Presence of Two Distinct Clones of Chronic Lymphocytic Leukemia and Plasma Cell Myeloma in a Patient
Authors
Sabina Langer
Meenal Mehta
Amrita Saraf
Aastha Gupta
Keyur Pipliya
Atul Kakar
Manorama Bhargava
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0512-7

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine